Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gain Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 50K | $125K | $2.50 | Apr 10, 2023 | Direct |
Gain Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 100K | Apr 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GANX | Gain Therapeutics, Inc. | Apr 10, 2023 | 2 | $0 | 4 | Apr 12, 2023 | Chief Financial Officer |
GANX | Gain Therapeutics, Inc. | Apr 10, 2023 | 0 | $0 | 3 | Apr 12, 2023 | Chief Financial Officer |